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Water molecules play a crucial role in mediating the interaction between a ligand and a macromolecule. The solvent environment
around such biomolecule controls their structure and plays important role in protein-ligand interactions. An understanding of the
nature and role of these water molecules in the active site of a protein could greatly increase the eﬃciency of rational drug design
approaches. We have performed the comparative crystal structure analysis of aldose reductase to understand the role of crystal
water in protein-ligand interaction. Molecular dynamics simulation has shown the versatile nature of water molecules in bridge
H bonding during interaction. Occupancy and life time of water molecules depend on the type of cocrystallized ligand present in
the structure. The information may be useful in rational approach to customize the ligand, and thereby longer occupancy and life
time for bridge H-bonding.
1.Introduction
Diabetes is a debilitating disease leading to severe compli-
cations and a shortened life expectancy. Diabetes-speciﬁc
microvascular disease leads to blindness, renal failure
and nerve damage, and diabetes-accelerated atherosclerosis
which increase risk of myocardial infarction, stroke, and
limb amputation [1]. The insulin therapy for tissues that
do not require insulin does not prevent complications such
as neuropathy, retinopathy, nephropathy, and cataracts [2].
Large prospective clinical studies show a strong relationship
betweenglycaemiaanddiabeticmicrovascularcomplications
in both type 1 and type 2 diabetes [3]. Hyperglycaemia and
insulin resistance are suggested to play important roles in the
pathogenesis of macrovascular complications [4].
Aldose reductase 2 (ALR2, alditol: NAD(P) 1-oxidor-
eductase, EC 1.1.1.21) is the ﬁrst enzyme in the polyol
pathway that catalyses the NADPH-dependent reduction of
Dg l u c o s et oDs o r b i t o l[ 5]. It is a cytosolic, monomeric
oxidoreductase that catalyses the NADPH-dependent reduc-
tion of wide variety of carbonyl compounds including
glucose [6]. Under diabetic hyperglycaemia, excess glucose is
metabolized by the polyol pathway (Figure 1). This pathway
comprised of two enzymes, namely, ALR2 which reduces
excessD-glucoseintoD-sorbitol,andsorbitoldehydrogenase
which converts sorbitol to fructose. Diabetic complications
have been linked to excessive accumulation of sorbitol, and
targeting the polyol pathway by inhibiting ALR2 oﬀers an
option for treatment [7].
In normal physiological conditions, ALR2 is involved in
osmoregulation while under hyperglycaemic conditions it
contributes to the onset and development of severe compli-
cations in diabetes [8]. The elevated glucose level enhances
the activity of ALR2 by directly increasing the glucose ﬂux
through this pathway and indirectly by forming reactive oxy-
gen species (ROS), which activates ALR2 [9]. The increased
activity of ALR2 results in decreased NADPH/NADP+ ratio,
and it aﬀects other NADPH-dependent enzymes, such as
nitric oxide (NO) synthase and glutathione reductase [10].
T h er e d u c t i o no fN Ol e v e ll e a d st od e c r e a s e sn e r v ec o n d u c -
tion and microvascular derangement. The retarded activity
of the antioxidative enzyme glutathione reductase causes2 Computational and Mathematical Methods in Medicine
Hyperglycemia
Polyol pathway
Glucose ALR2 Sorbitol SDH Fructose
NADPH
NO GSH
Oxidative stress AGEs
Glycation
3-deoxycholate
Fructose-3-phosphate
Figure 1: Hyperglycemia pathway.
oxidative stress under diabetic conditions [11]. Inhibiting
ALR2 would provide a way of avoiding diabetic complica-
tions, and, therefore, identifying inhibitors is an important
pharmaceutical goal.
Epalrestat is the only inhibitor of aldose reductase that
is successfully marketed in Japan for treatment of diabetic
neuropathy. Many promising compounds from diﬀerent in
vitro and in vivo studies have failed to proceed beyond
clinical trials. The lack of eﬃcacy or adverse eﬀects as a
result of less-speciﬁc inhibitor, and a likely inhibition of the
related aldehyde reductases are the major bottlenecks in the
development of ALR2 inhibitors. The knowledge of catalytic
mechanism and available structures information of current
inhibitors coupled with ALR2 can help in accelerating the
discovery or designing of speciﬁc inhibitors. A limited
number of currently available drugs for the treatment of
diabetic complications only suggests the importance of
research for new ALRIs [12].
ALR2 is a monomer (35.8kDa), encoded by a single
gene located on chromosome region 7q35.ALR2, made up
of a single polypeptide chain with 315 residues. The crystal
is a single domain structure folded into an eight-stranded
parallel α/β motif. The substrate-binding site is located in a
cleft at the carboxy terminal end of the β-barrel and involves
loop residues. The large and highly hydrophobic active site
is located at the carboxy terminus of (β/α)8 barrel. To date,
there are 95 crystals of ALR2 deposited in Protein Data
Bank [13]. The ligand-binding site is a large, deep, elliptical
pocket with the nicotinamide ring of NADPH cofactor lying
at the base. The enzyme has anion-binding pocket and
speciﬁcity pocket (Figure 2). The anion-binding pocket has
Tyr 48, His110, Trp111, Trp 20, Phe122, and Trp 219 while
the speciﬁcity pocket is lined by residues Trp111, Thr113,
Phe122, Ala 299, and Leu 300.
Wepresentheremoleculardynamicssimulationstudyon
the crystal structure of ALR2 enzyme. Moreover, the goal
of our study is to evaluate the importance of the crystal
water molecule in the active site of the ALR2. These water
molecules mediate the hydrogen bond and help ALRIs to
bind at the active site.
2.MaterialsandMethods
2.1. Comparative ALR Crystal Structure Analysis. The 87
crystal structures of human ALR were obtained from the
Protein Data Bank (PDB) [13]. The crystals were aligned
by “Align by homology” program in Biopolymer module
in Sybyl7.1, taking the apoenzyme (PDB id: 1ADS) as theComputational and Mathematical Methods in Medicine 3
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Figure 2: Schematic drawing of ALR2 binding pocket.
reference structure [14]. The crystals were analyzed for the
presence of ordered/conserved water molecules in the active
site using PyMol [15].
2.2. Preparation of Input Files for MD Simulation. Among
all available crystal structures of human ALR2, ﬁve crystal
structures having diﬀerent ligand (PDB id: 1T40, 1Z89,
2FZ8, 3H4G, and 3G5E) were selected to understand the role
of water molecules in the binding of ligands with human
ALR2[13].Coordinatesofcrystalstructuresweretakenfrom
the PDB. Missing residues were added, and mutated residues
were corrected to wild-type residues using Schrodinger
maestropackage[16].Missinghydrogenatomsofligandsand
cofactors were added using Schrodinger maestro package.
AM1-BCC charges were used for the ligands as well as
cofactor NADPH, calculated using Antechamber program.
Parameters for the ligands were generated using the general
amber force ﬁeld (GAFF) and Antechamber module of
AMBER while ﬀ99SB force ﬁeld was used for protein.
Missinghydrogenatomsoftheproteinstructureswereadded
using LeaP module of AMBER. Amino acids were kept
in their default ionization states. Crystal water molecules
were kept as such while preparing the system. Complex
was solvated using orthorhombic TIP3P water box, distance
between the edge of the box, and periphery of the protein is 8
Angstrom [17]. Solvated systems were neutralized by adding
required number of counter ions. A two-stage approach
was adopted for minimizing the protein. In the ﬁrst stage,
the protein, ligand, and cofactor were kept ﬁxed with weak
restraint (10kcal/mol-˚ A2), and only solvent was allowed to
minimized. Then, in the second stage, the entire system
was minimized. Initially, minimization of 1000 steps of
steepest descent was carried out and this was followed
by another 500 steps of conjugate gradient minimization.
Thereafter, minimizing solvent, the entire system consisting
water, protein, and ligand cofactor was minimized for 2500
steps without restraint.
After minimization process, the system was heated from
0 to 300K. In order to avoid any instability during the
MD production run, an initial MD run were carried out in
NPT ensemble (pressure = 1bar ,temperature= 300Kel) to
equilibrate the system for 20ps with weak restraints on the
solute. Production run were carried out for 5ns time, using
NVT ensemble and Langevin dynamics used to control the
temperature through a collision frequency of 1.0ps−1 [18].
Step size was kept 2fs for the throughout simulations. A
SHAKE algorithm was applied to constrain bonds involving4 Computational and Mathematical Methods in Medicine
Table 1: Table showing PDB ID of complexes and their inhibitors and water molecules in the active site.
PDB ID Ligand Ligand atom ID Water molecule ID
1AZ1 Alrestatin O21 HOH669
1PWL Minalrestat O HOH2323
1PWM Fidarestat F17
N21
HOH1654
HOH1552 & 1774
1IEI Zenarestat O34 HOH477
1T40 IDD552 O16 HOH738
1T41 IDD552 O16 HOH5004
1Z89 Sulfonyl pyridazinone O18 HOH1147
1Z8A Sulfonyl pyridazinone O18 HOH1179 & 1268
2ACQ G6P G6P317 HOH460
2ACU CIT CIT317 HOH319
2FZ8 Zopolrestat O1 HOH1082
2FZD Tolrestat S1
F3
HOH355 & 389
HOH487
2PD5 Zopolrestat O1 HOH748
2PD9 Fidarestat N21 HOH624&816
2PDF Zopolrestat O1 HOH815
2PDI Zopolrestat O1 HOH736 & 687
2PDM Zopolrestat O1 HOH782
2PDW Fidarestat N21 HOH 750 & 615
2PDX Zopolrestat O1 HOH 691
2PDY Fidarestat N21 HOH 617
3H4G Fidarestat N21 HOH 2275
3G5E Q74 N24 HOH 698
hydrogen atoms [19]. The van der Waals cutoﬀ was kept
8 angstrom and long range electrostatic interactions were
treated using the Particle Mesh Ewald (PME) method. Co-
ordinates were saved after each 1000 step, which were ﬁnally
used for analysis.
AllsimulationswerecarriedoutusingSANDERprogram
of AMBER10 package. Analysis was performed using VMD
andPtrajmoduleofAmbertools[20].Additionally,Chimera
and Pymol were used for molecular visualization [21].
2.3. MM-PB (GB) SA Calculations. MMPBSA calculations
were performed on 5 complexes: 1T4O, 1Z89, 2FZ8, 3H4G
and 3G5E. The interaction energy and salvation-free energy
forthecomplex,receptor,andligandwerecalculatedwiththe
help of the snapshots extracted at each 10ps from the 1.5ns
to 5ns run. The average of the results was calculated to get
an estimate of the binding free energy. The binding energy
calculation was carried out with MM PBSA and MM GBSA
method for the sake of comparison. Additionally, binding
energieswerealsoestimatedbyMM-PBSAprogramofPrime
module of Schrodinger maestro package.
3. Results andDiscussion
3.1. Comparative Crystal Structure Analysis of ALR2 Com-
plexes. All the 87 crystal structures of human ALR2 were
aligned by “Align by homology” program in Biopolymer
module in Sybyl7.1, taking the apoenzyme, 1ADS as a ref-
erence structure. This module aligns proteins on the basis of
their sequence similarity. The tailor variables control the gap
penalty, the number of jumbles, and similarity matrix used.
The sequences were compared by superimposing the Cα,
backbone, side chain, and all atoms. The crystal structures
having a RMSD value greater than 0.5 ˚ Aw e r er e j e c t e d .T h e
selected 28 crystal structures were analyzed using Accelrys
DiscoveryStudio2.0[22]andPymoltovisualizeandidentify
atomsparticipating intheligandbindingincluding thewater
molecules in the active site. After analyzing the atoms, 23
crystal structures were found to have water molecules in the
active site which showed hydrogen bond interactions.
The criterion in selecting the hydrogen bonds was the
bond length that should not be greater than 3 ´ ˚ A. The active
site was observed to have more number of bridging water
molecules within the anionic pocket of NADPH rather than
the ligand (Table 1). We assumed that the phosphate groups
present in the NADPH are responsible for it. The ligands
were found to interact with at least one water molecule in
the active site. The water molecules are said to be bridging if
they simultaneously make hydrogen bonds with both ligand
and amino acid residues.
3.2. Analysis of Ligand-Binding Site. The crystal structures,
1T40,1Z89,2FZ8,3H4G,and3G5E,wereselectedforfurther
studies. The active sites were analyzed around 5 ˚ Ar e g i o nComputational and Mathematical Methods in Medicine 5
(a) (b)
Figure 3: Water molecule interacting with ligand in crystal structure (a) 2FZ8 and (b) 3H4G. The ligand and the amino acid residues in the
active site are represented in stick. The yellow broken line represents the hydrogen bond between the ligand and the active site residues.
of ligand to identify the number of water molecules and
hydrogen bond interactions with corresponding ligand. It
was noted that most of the structures have at least one
water molecule in the active site which shows hydrogen
bond interactions with the ligand. In Figure 3, the ligands
of 2FZ8 and 3H4G make a hydrogen bond with the water
molecule at the active site. All the ligands, except in 1Z89,
displaced the 9 ordered water molecules in the active site
of the apoenzyme, whereas the ligand in 1Z89 displaced 6
water molecules. These diﬀerences can be attributed to the
size and conformation of the ligand in the active site. The 5
complexes, upon superimposing on the apoenzyme, showed
their ligands, displacing the 6 ordered water molecules in
the active site of the apoenzyme. The size of the ligand
from 3H4G is exactly equal to the size occupied by the 6
ordered water molecules in the apoenzyme; whereas, the
other ligands have an extended conformation in both the
anionic and speciﬁcity site.
3.3. Binding Free Energy Calculations. Explicit solvent MD
simulations were carried out for all complexes under study.
The absolute binding free energy of the complex formation
was estimated from energetic and entropic contributions,
and calculated for snapshots extracted from the trajectories.
The snapshots of the unbound proteins and complexes were
taken from molecular dynamics (MD) and were further
processed for 2ns using periodic boundary conditions. The
snapshots of the unbound molecules were extracted only
from the trajectory of the solvated complex. A total of 1000
snapshots were extracted from the 2ns trajectory, with 200
snapshots for each of the solvated complex.
Solvation free energies were computed as the sum
of polar and nonpolar contribution, using a continuum
representation of the solvent. The polar contribution was
calculated by solving the Poisson equation. The nonpolar
contribution to the solvation free energy due to cavity
formationandvanderWaalsinteractions,betweenthesolute
and the solvent, was estimated by a solvent-accessible surface
area. The total binding energy was negative in all the com-
plexes, and it signiﬁes a favorable protein-ligand complexes.
The results for the binding free energy after performing
simulation for 2ns are shown in Table 2. Although the result
shows zopolrestat, the second potent ligand (2FZ8) has the
highest binding aﬃnity, while sulfonyl pyridazinone (1Z89)
hasthelowestbindingaﬃnity.Theinhibitorshavemaximum
potency diﬀerence of 2.8 between most and least potent
ligand at scale of pIC50. It indicates coinciding nature of
biological activity which merely expected to be demarcated
by correlation with predicted binding free energy due to lack
of wide range.
The electrostatic contribution to solvation free energy in
the5complexesisshowninTable 3.TheΔGele andΔGvdW are
electrostatic (ELE) and van der Waals (VDW) contribution,
calculated by the MM force ﬁeld respectively. The ΔGele-int
is the internal energy (INT) arising from bond, angle, and
dihedral terms in the MM force ﬁeld. The sum of ELE,
VDW, and INT is known as total gas phase energy. The
ΔGnon-polar is the non-polar contribution to the solvation
free energy calculated by an empirical model while ΔGele-MM,
is sum of the electrostatic solvation free energy and MM
electrostatic energy. 1Z89 makes the highest contribution to
the solvation free energy while 3G5E makes the lowest. The
nonpolar contributions to the solvation are similar in all the
ﬁve complexes. Electrostatic component of the solvation free
energy was calculated by GB model. Polar contributions to
the solvation free energy were computed by applying linear
PB model and an extension to the GB model. It disfavors
binding of the protein ligand complexes in ALR2. PB and GB
calculations give very similar results in that respect.
Moreover, the ΔGbind calculated for the ALR2 crystal
structure with and without crystal molecules was found6 Computational and Mathematical Methods in Medicine
Table 2: IC50 and calculated binding free energy for ALR2 crystal structure complexes.
S.No. PDB ID Structure IC50(μM) ΔGbind
11 T 4 0
O
HO
O
O
HN S
N
F
F
F
F
0.0110 −33.88
21 Z 8 9
NN H
O S
O
O O
Cl
0.0010 −22.24
32 F Z 8
N
N
O
OH
S
N
F
F
F
O
0.0031 −35.22
43 H 4 G
O
HN
NH
O
O
F
O
NH2
0.5700 −31.02
53 G 5 E
O
HO
N N
S
N
F
F
F
0.0050 −29.17
reasonable. The binding energy of the ALR2 complexes
without crystal water was observed low by 3–7kcal/mol as
compared to complexes with water. It clearly indicated that
crystal water molecules helped in making strong and stable
protein-ligand complexes (Table 3).
3.4. Molecular Dynamics Simulation with Crystallized Water
Molecules. Explicit simulations were carried out for the
crystal structures—1Z89, 2FZ8 and 3H4G (Figure 4). The
crystallized water molecules were retained in this simulation.
T h en o t i o no fc r y s t a lw a t e r si st r i c k yi nM Ds i m u l a t i o n
since water is highly mobile and therefore, they exchange
rapidly.Evenattightinterfaces,suchasaprotein-nucleicacid
interface,thelifetimesofboundwaterareonthenanosecond
timescale.Hence,thewatersinthesolvationshellaroundthe
ligandwerecalculatedafterprocessingofthetrajectorieswith
ptraj module of AMBER. The output for this functionalityComputational and Mathematical Methods in Medicine 7
Table 3: Thermodynamics of binding for the 5 complexes of ALR2 calculated using MM-PBSA.
PDB ID ΔGele ΔGvdW ΔGele-int ΔGnon-polar ΔGele-MM
ΔGbind
∗ Gbind
∗
(With water) (Without water)
1T40 5.97 −48.31 14.96 −5.67 20.93 −25.24 −21.29
1Z89 −6.92 −44.85 36.83 −4.94 29.91 −53.71 −49.73
2FZ8 5.66 −51.96 21.49 −6.07 27.16 −18.77 −16.23
3H4G 11.81 −45.37 17.53 −5.69 29.34 −44.16 −36.60
3G5E 22.7 −46.89 4.79 −5.44 27.49 −17.55 −14.22
∗Estimated by MM-GBSA program of Prime module implemented in Schrodinger maestro package.
(a) (b)
Figure 4: Water molecules present in the apoenzyme (red dot) displaced by the ligand in crystal structure (green dot) (a) 2FZ8 and (b)
3H4G. The ligand in the active site is represented in stick.
contains number of waters in the ﬁrst shell and second
shell. The ﬁrst solvation shell represents a distance of 3.4 ˚ A
from the solute, that is, ligand of interest while the second
solvation shell represents a distance of 5 ˚ A from the center of
mass of the ligand. The analysis is presented separately for
each complex.
3.4.1. Analysis for the Complex 1Z89. 1Z89 is a human ALR2,
coupled with novel sulfonyl-pyridazinone (62P), having a
resolution of 0.95 ˚ A. The pyridazinone groupof the inhibitor
occupies the catalytic site, whereas the chlorobenzofuran
moiety penetrates the open speciﬁcity pocket. The pyridazi-
none exhibits a binding aﬃnity similar to that of tolrestat
and sorbinil, showing slightly reduced aﬃnity compared to
IDD594. The 62P displaces the 6 ordered water molecules
which are present in the apoenzyme 1ADS, whereas other
ligands replaced 9 water molecules in the apoenzyme. From
the analysis of the crystal, it was observed that O18 of the
ligand made hydrogen bond interactions with HOH1147.
The other hydrogen bond interactions were observed for
O7 with OH of Tyr48, and NE2 of His110 and N4 with
NE1 of Trp111. As the simulation progressed the positions
of water molecules ﬂuctuated as indicated by graph from
Figure 5(a). The graph shows the movement of water
molecules within the ﬁrst and second solvation shell
throughout the simulation. The water molecule is stable for
the location of the oxygen atom, but it tumbles freely with
thehydrogenatomsjumpingbetweenseveralpositionsofthe
hydrogen bond network. The plot for the number of water
molecules ﬂuctuating throughout the simulation during the
explicit 5ns is shown in Figure 5(a).
The number of water molecules in the ﬁrst solvation
shell was found to be 1 on an average throughout the
5ns simulation. However, in the second solvation shell,
there were 3 water molecules on an average. To understand
the water association, visual analysis of the areas of high
occupancy or search, a speciﬁc water interaction is useful
(Table 4). The occupancy is deﬁned as the percentage over
the whole trajectory in which both the distance and the angle
criteria are satisﬁed.
Agridof100angstromswasgeneratedaroundthesolute.
The structure was ﬁtted to a common reference frame, by
RMS ﬁt to the ﬁrst frame, to all the solute molecules in the
protein. If the molecule is tumbling in space that ﬁxed water
will move with the molecule but the grid does not, it is ﬁxed
at the ﬁrst frames location. If the water in question is in the
samepositionwithrespecttothebiomolecule,thenthewater
molecules will move with the side chain. Since the grid did
not move, the density can be smeared across multiple grid
elements. This will give an idea of the probable involvement8 Computational and Mathematical Methods in Medicine
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Figure 5: (a) Number of water molecules ﬂuctuating in the solvation shell of 62P during 5ns simulation and (b) ligand 62P interacting with
HOH1147.
Table 4: Hydrogen bonds data showing occupancy with distance
cutoﬀ of 5 ˚ A along the MD simulations for 1Z89.
Donor H-X Acceptor
atom of water
1Z89
Occupancy
(%) Distance (˚ A)
62P@O18 8106@O 16.50 3.517
62P@S8 8106@O 14.50 3.753
62P@O19 8106@O 14.00 3.723
62P@N4 8106@O 11.50 3.986
62P@C3 8106@O 11.00 3.730
of water molecules in the active site of the protein as the
simulation progresses.
The hydration site was constructed from the water den-
sity by using the coordinate system local to each hydration
site. The water structure is broken down into hydration sites
constructed from water density from the protein surface.
This gives the structural and dynamic properties of the water
molecules from the explicit simulations. Properties studied
include site occupancy, number of neighboring waters and
hydrogen bonds. The occupancy of water around the ligand
sulfonyl pyridazinone is analyzed by Chimera. From the
density map, it was observed that the density is concentrated
around O18 and O7 of the ligand, which in the native crystal
was making a hydrogen bond with the water molecule.
It is shown in the surface representation of the protein
thatligandismakingahydrogenbondwithawatermolecule,
HOH 1147 (Figure 5(b)). In this simulation, the crystal
waterswereremoved,butthewaterdensityaroundtheligand
shows the positions of the water molecule being retained,
thatis,theywereoccupiedbythewatermoleculeswhichwere
added explicitly. The density was at the same position where
the ligand was making a bond with the water molecule, and
the same pattern was observed in the remaining complexes
also. This shows that positions of the water molecules are
conserved in all the complexes belonging to this family.
3.4.2. Analysis for the Complex 2FZ8. The bound zopolrestat
occupiesalmosttheentireactivesitepocketattheC-terminal
end of the β barrel. The inhibitor makes an unusually
large number of contacts with the active site. It made a
total of 132 contacts within ≤4 ˚ A, 110 with 15 residues, 13
with the nicotinamide moiety of the coenzyme, and 9 with
four ordered water molecules coenzyme. This contributes
favorable entropic eﬀect to the tight binding of the inhibitor.
From our analysis, we found out that the ligand displaces 9
water molecules present in the apoenzyme. The O1 of the
ligand makes a hydrogen bond with HOH1082. The other
water molecules were also present in the active site, but they
did not make any interactions with the ligand. The other
hydrogen bond interactions were made between O3 of the
ligand with OH of Tyr 48, and NE2 of His110; O2 of ZST
with NE1 of Trp111, and N3 with N of Leu300.
The neighboring water molecules in the active site were
studied. The number of waters in the ﬁrst solvation shell,
around the ligand in 2FZ8, was 6 throughout the simulation,
whereas,inthesecondsolvationshellitwas13onanaverage.
The number of water molecules in the ﬁrst and second
solvation shell, is plotted as the number of water molecules
against the number of frames in the graph (Figure 6).
The occupancy of water oxygen atom with the ligand
throughout 5ns simulation per frame is shown in Table 5.
The highest occupancy was approximately 53% for 2FZ8
in diﬀerent frames during the simulation, and it gradually
reduced to 15% as the simulation progressed.
3.4.3. Analysis for the Complex 3H4G. 3H4G is an ALR
crystal structure with Fidarestat (FID), which was shown to
have implications in inhibitor binding and selectivity. The
ligand displaces 9 water molecules in the active site of theComputational and Mathematical Methods in Medicine 9
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Figure 6: (a) Number of water molecules ﬂuctuating in the solvation shell of ZST during 5ns simulation, and (b) ligand ZST interacting
with HOH1082.
Table 5: Hydrogen bonds data showing occupancy with a distance
cutoﬀ of 5 ˚ A for 2FZ8 during the MD simulations.
Donor H-X Acceptor atom
of Water
2FZ8
Occupancy
(%) Distance (˚ A)
ZST@C9 328@O 53.55 3.730
ZST@N3 328@O 49.73 4.378
ZST@C10 328@O 46.45 4.435
ZST@N1 328@O 36.09 4.614
ZST@O1 328@O 15.00 4.747
apoenzyme. A bridging water molecule HOH2275 is present
between the ligand and the protein, making hydrogen bond
interactions with N21, O10 of FID, and HOH 2015. The O6I
of FID makes a hydrogen bond with NE1 of Trp114. Also,
O10 of FID makes a hydrogen bond with HOH 2196, and O3
of the ligand with OH of Tyr 50.
T h ee x t e n to fs o l v e n te x p o s u r ef o re a c hs i t ei sm e a s u r e d
by the average number of neighboring waters within the cut-
oﬀ distance 3.5 ˚ Aa n d5˚ A, of all waters that exist in the ligand
active site, as shown in the graph (Figure 7). The number
of water molecules in the ﬁrst solvation shell around the
ligand in 3H4G was 3 throughout the simulation, whereas it
was 6 at an average in the second solvation shell. Figure 6(b)
shows a picture of the protein surface, and the ligand in stick
representation, interacting with water molecules displayed as
red spheres. Here, the ligand is interacting with more than
one water molecule in the active site.
Table 6 shows the occupancy of water oxygen atoms
with the ligand throughout the simulation for diﬀerent
frames. The occupancy and the hydrogen bond distances
were monitored throughout the simulation. Initially, the
highest occupancy was 98%, and it got reduced to 89% as
the simulation progressed. The occupancy of water in this
protein was the highest when compared to other proteins in
this study, and this also conﬁrmed the sharp hydration sites.
Table 6: Hydrogen bonds data showing occupancy with a distance
cutoﬀ of 5 ˚ A in the MD simulations for 3H4G.
Donor H-X Acceptor
atom of water
3H4G
Occupancy
(%) Distance (˚ A)
FID@C9 346@O 98.82 3.683
FID@O10 346@O 97.55 3.765
FID@C11 346@O 95.27 4.047
FID@C19 346@O 91.91 4.299
FID@O6I 346@O 89.64 3.423
Concurrently, decreasing numbers of water molecules
are observed in both the hydration shell (Figures 5(a), 6(a),
and 7(a)). Although the active site of the ALR2 is highly
hydrophobic, and water molecules are observed present at
the opening of the active site cavity, the region included
in the hydration shell. The water molecules are randomly
moved away with progress of simulation while the average
numberofsolventwatermoleculesremainedsimilartowater
molecules present in the crystal structures. The bridge H-
bondinginteractionisbelievedtokeepthesewatermolecules
in the highly perturb site. Moreover, no severe structural
changes are observed as the average backbone root mean
square deviation (RMSD) is found <0.72 ˚ Aa n d<0.89 ˚ Af o r
active site residues (5 ˚ A regions around cocrystal ligand) and
whole protein respectively (Figure 8).
4. Conclusions
The traditional approaches for absolute free energy esti-
mation in the MM-PB(GB)SA approach, no “nonphysical”
annihilation or decoupling of the ligand in solution and
bound to its receptor is necessary, nor need one simulate
the partially unbound states that would be required for a
potential of mean force estimate using umbrella sampling.
Hence,bindingfreeenergycalculationswithMM-PB(GB)SA
use physical states at both end points of the binding reaction10 Computational and Mathematical Methods in Medicine
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Figure 8: RMSD of backbone is shown for whole protein (blue) and 5 ˚ A regions around the active site of cocrystal ligand (red). The
structures, 1Z89 (a) and 3H4G (c), have lower RMSD for active site than whole protein, while 2FZ8 (b) has similar RMSD for both
throughout the trajectory.
only, thereby, avoiding the need to devote computer time on
intermediate states. Because the accuracy of absolute binding
free energy calculations depends on a delicate balance of
diﬀerent energetic and entropic contributions, the calculated
in silico binding free energy can be still considered close to
the experimentally determined data.
The water density around the ligand shows areas of high
occupancyofwateratthesepositions.Theycloselyreproduce
the position of the water molecules which were observed in
the crystal structure. The life time and occupancies of water
molecules also varies depending on the type of inhibitor
with 3H4G having occupancy of 98.92%, 53.55% for 2FZ8,
and only 16.5% for 1Z89. The occupancy ratios are also
in agreement with the observed density, in which 3H4G
have more density around the ligand when compared to
other inhibitors. The contributions toward electrostatic free
energy of solvation are very low for 3H4G as compared
to other complexes. So the energy required to desolvate
the binding particles in this complex is very low, while the
highest energy required to desolvate is seen in 1Z89 which
has a low binding energy. Moreover, binding energy pattern
of the ALR2 complexes with and without water signify
the importance of the water molecules in protein-ligand
interaction. This study conﬁrmed the stability of structural
bridgewatermoleculesthatarealwayspresentinsimulations
and also revealed the presence of other structural water
molecules, with lower residence time and occupancy in the
complexes.
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